Post by California Institute for Regenerative Medicine (CIRM)

Infrastructure is essential to moving promising research toward patients. The UCLA Health Center for Advanced Biotherapies will expand on-campus manufacturing capacity for cell and gene therapies, supporting a wider range of personalized treatments and helping researchers move therapies into early clinical trials more efficiently. CIRM invested $2 million in this significant initiative, underscoring the commitment to advancing regenerative medicine and gene therapy in California. These investments not only build essential capacity for innovative treatments but also nurture the next generation of scientific leaders. Read more: https://lnkd.in/en57gPg2 UCLA Broad Stem Cell Research Center UCLA Health UCLA Health Jonsson Comprehensive Cancer Center